Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?

Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?

Bibliographic Details
Main Authors:	Cristiane J. Gomes-Lima, Wen Zhou, Zoe Quandt
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Endocrinology
Subjects:	immune checkpoint inhibitors (ICI) immunotherapy cancer adverse events endocrine glands
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1268402/full

Similar Items

Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series
by: Antonella Laria, et al.
Published: (2021-08-01)

Endocrine side effects of immune checkpoint inhibitors
by: Zulma Cardona, et al.
Published: (2023-05-01)

Editorial: Immune checkpoint inhibitors in renal cell carcinoma
by: Scott S. Tykodi, et al.
Published: (2023-04-01)

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment
by: Sridha Ganesh, et al.
Published: (2022-09-01)

Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency
by: Jing Xiang, et al.
Published: (2023-12-01)

Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
by: Yanting Zhou, et al.
Published: (2023-06-01)

Challenges and Limitations of Endocrine Toxicity Evaluation in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy—Retrospective Study from a Tertiary-Level Hospital in Romania
by: Simona Coniac, et al.
Published: (2023-05-01)

Immune checkpoint inhibitor‐mediated psoriasis treated with biologics
by: Pei Ming Yeo, et al.
Published: (2023-06-01)

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives
by: Brigida Anna Maiorano, et al.
Published: (2021-09-01)

Perspectives on Psoriasiform Adverse Events from Immune Checkpoint Inhibitors: Lessons Learned from Our Practice
by: Liliana Gabriela Popa, et al.
Published: (2024-02-01)

Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
by: Betul Ibis, et al.
Published: (2023-06-01)

Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study
by: Huixia Li, et al.
Published: (2023-04-01)

Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
by: Heidar J. Albandar, et al.
Published: (2021-02-01)

Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research
by: Jun Zhao, et al.
Published: (2024-04-01)

Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review
by: Naoko Okura, et al.
Published: (2020-06-01)

Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge
by: Martina Catalano, et al.
Published: (2022-12-01)

Case report: Pneumonia with clinical symptoms precedes imaging evidence after immune checkpoint inhibitors combined with radiotherapy in lung squamous cell cancer
by: Yao Wang, et al.
Published: (2022-09-01)

Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
by: Hyemi Kwon, et al.
Published: (2022-12-01)

Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy
by: Adrian Chye, et al.
Published: (2022-07-01)

A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors
by: Oren Levine, et al.
Published: (2017-08-01)

Imaging assessment of toxicity related to immune checkpoint inhibitors
by: Antonia M. Berz, et al.
Published: (2023-02-01)

Achilles’ Heel of currently approved immune checkpoint inhibitors: immune related adverse events
by: Ting Yan, et al.
Published: (2024-02-01)

Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario
by: Calogera Claudia Spagnolo, et al.
Published: (2022-12-01)

Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database
by: Hou-Ting Kuo, et al.
Published: (2024-01-01)

Pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis
by: Zhe Zhao, et al.
Published: (2023-06-01)

Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States
by: Fan Yang, et al.
Published: (2023-01-01)

A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer
by: Yue Hu, et al.
Published: (2023-04-01)

Editorial: Immune-related adverse events for patients with lung cancer-volume II
by: Yusha Wang, et al.
Published: (2023-11-01)

Incidence of Immune Checkpoint Inhibitor–Induced Myocarditis During the COVID‐19 Pandemic
by: Alexi Vasbinder, et al.
Published: (2024-03-01)

Impact of antibiotics on the efficacy of immune checkpoint inhibitors in the treatment of primary liver cancer
by: Jia-Ren Wang, et al.
Published: (2022-09-01)

Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit
by: François Deharo, et al.
Published: (2022-09-01)

Editorial: The role of immune checkpoints in gastrointestinal diseases
by: Xiaofei Shen, et al.
Published: (2023-07-01)

Immune checkpoint inhibitor-induced endocrinopathies: a possible indicator of improved survival
by: Mariana Ornelas, et al.
Published: (2023-07-01)

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
by: Randolph J. Noelle, et al.
Published: (2023-09-01)

Ocular Inflammation Induced by Immune Checkpoint Inhibitors
by: Florence Chaudot, et al.
Published: (2022-08-01)

Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
by: Xueyan Wang, et al.
Published: (2022-10-01)

Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival
by: Lorena Villa-Crespo, et al.
Published: (2022-02-01)

Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
by: Ranferi Ocaña-Guzmán, et al.
Published: (2023-08-01)

Cardiotoxicity of checkpoint inhibitors: focus on immune side effects
by: Yuri I. Buziashvili, et al.
Published: (2024-04-01)

Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
by: Prasanna Duraisamy, et al.
Published: (2023-07-01)